Allele Symbol Allele Name Allele ID |
Neurog3tm1.1(cre/ERT)Ggu targeted mutation 1.1, Guoqiang Gu MGI:3796207 |
||||||||||||||||||||||||
Summary |
5 genotypes
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
• fewer cells are induced to produce glucagons than in Pdx1tm1Macd/Pdx1+ Tg(tetO-Neurog3)8Ggu mice
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
• in male mice 4 weeks after tamoxifen treatment
|
• in male mice 12 weeks after tamoxifen treatment
|
• 12 weeks after tamoxifen treatment, postglucose-challenge-serum-insulin levels are decreased unlike in similarly treated wild-type mice
|
• in female mice 2 and 3 months after tamoxifen treatment and in male mice 12 weeks after tamoxifen treatment
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
• at 6 weeks compared to in Neurog3tm1(cre/ESR1)Ggu/Neurog3tm1.1(cre/ESR1)Ggu mice
|
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 11/19/2024 MGI 6.24 |
|
|